| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 4.05M | — |
| Operating expense | — | — |
| Net income | -55.43M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ABCL returned +157.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +231.0% |
| 1 year | +157.9% |
| 5 years | -32.5% |
| All-time high | $52.83 (Jan 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ABCL would be worth today ›No. AbCellera Biologics Inc. has not paid a dividend in the past 12 months.
AbCellera Biologics Inc. stock trades on NASDAQ under the ticker symbol ABCL.
AbCellera Biologics Inc. is part of the Healthcare sector.
AbCellera Biologics Inc. has a market cap of 3.67B USD, based on the latest quote.
AbCellera Biologics Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
